banner_advertise_728

Global pharmacogenetics: giving the genome to the masses.

Authors:
Sharon Marsh
Sharon Marsh
Washington University School of Medicine
United States
Howard L McLeod
Howard L McLeod
University of North Carolina
United States

Pharmacogenomics 2006 Jun;7(4):625-31

Washington University School of Medicine, Department of Medicine, Room 1021 CSRB NT, 660 South Euclid Avenue, Campus Box 8069, St Louis, MO 63110, USA.

With pharmacogenetics comes the promise of individualized therapy selection for many common diseases where multiple treatment options are available. Recent advances including the Human Genome Project, the International HapMap project, advances in throughput and reduction in cost of genetic testing, and the inclusion of genotype-related dosing recommendations into package inserts all point to the integration of pharmacogenetics into clinical practice. However, many countries will not have access to pharmacogenetics resources in the near future. Generation of global genotype profiles will provide a useful, but not perfect resource for incorporating pharmacogenetics into national drug formularies in the form of prioritization or surveillance where individual genotype data would not be attainable. The PharmacoGenetics for Every Nation Initiative is a first step to making pharmacogenetics applicable on a global level.

Download full-text PDF

Source
http://dx.doi.org/10.2217/14622416.7.4.625DOI Listing
banner_advertise_728
June 2006
7 Reads

Publication Analysis

Top Keywords

pharmacogenetics
6
resources future
4
pharmacogenetics resources
4
will access
4
countries will
4
access pharmacogenetics
4
future generation
4
profiles will
4
genotype profiles
4
global genotype
4
generation global
4
practice countries
4
pharmacogenetics clinical
4
genotype-related dosing
4
inclusion genotype-related
4
testing inclusion
4
genetic testing
4
dosing recommendations
4
recommendations package
4
will provide
4

Similar Publications